Root Jonathan D
- SEC CIK
- 0001225480
No open-market purchases or sales filed in the past year.
Current role at each company
- EWTX Edgewise Therapeutics, Inc.Directoras of Jul 17, 2026
- OMDA Omada Health, Inc.Directoras of Jul 7, 2026
- CARL Carlsmed, Inc.Directoras of Jun 22, 2026
- NARI Inari Medical, Inc.Directoras of Feb 19, 2025
- EFTR eFFECTOR Therapeutics, Inc.10% Owneras of Aug 3, 2022
Show 1 more company
- SPRY ARS Pharmaceuticals, Inc.Directoras of Jun 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Root Jonathan D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CARL Carlsmed, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2025 (view filing) | Jul 24 | Same day | Root Jonathan DDirector | PPurchase | +466.7K | $15.00 | +$7.00M | +2,692.4%484.0K after |
EFTR eFFECTOR Therapeutics, Inc.
10% Owner14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 (view filing) | Nov 9-12 | 3 days | Root Jonathan DDirector, 10% Owner | SSale | −86.8K | $10.56 | −$917.1K | −37.2%146.8K after | 8 lots |
| Nov 17, 2021 (view filing) | Nov 15-17 | 2 days | Root Jonathan DDirector, 10% Owner | SSale | −23.6K | $9.38 | −$221.6K | −13.9%146.1K after | 6 lots |
| Nov 22, 2021 (view filing) | Nov 18-22 | 4 days | Root Jonathan DDirector, 10% Owner | SSale | −50.2K | $8.12 | −$407.4K | −25.8%144.5K after | 6 lots |
| Nov 26, 2021 (view filing) | Nov 23-26 | 3 days | Root Jonathan DDirector, 10% Owner | SSale | −56.4K | $7.34 | −$414.1K | −28.3%142.8K after | 6 lots |
| Dec 1, 2021 (view filing) | Nov 29-Dec 1 | 2 days | Root Jonathan DDirector, 10% Owner | SSale | −72.4K | $6.57 | −$475.5K | −34.0%140.5K after | 6 lots |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Root Jonathan DDirector, 10% Owner | SSale | −8.11K | $5.68 | −$46.1K | −5.5%140.3K after | 2 lots |
| May 11, 2022 (view filing)8:10 PM ET | May 9-11 | 2 days | Root Jonathan D and 4 others10% Owner | SSale | −49.0K | $2.42 | −$118.4K | −26.1%138.7K after | 6 lots |
| May 16, 2022 (view filing)6:36 PM ET | May 12-16 | 4 days | Root Jonathan D and 4 others10% Owner | SSale | −46.2K | $1.85 | −$85.5K | −25.2%137.3K after | 6 lots |
| May 19, 2022 (view filing)6:16 PM ET | May 17-19 | 2 days | Root Jonathan D and 4 others10% Owner | SSale | −34.4K | $1.73 | −$59.5K | −20.2%136.2K after | 6 lots |
| Jul 19, 2022 (view filing)4:54 PM ET | Jul 15-19 | 4 days | Root Jonathan D and 4 others10% Owner | SSale | −69.6K | $1.10 | −$76.3K | −34.2%134.1K after | 6 lots |
NARI Inari Medical, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 (view filing) | Jun 22, 2020-Nov 15, 2021 | 634 daysLate | Root Jonathan DDirector | PPurchase | +335 | $85.02 | +$28.5K | New position335 after | 2 lots |
SPRY ARS Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 (view filing) | Mar 3-Nov 15, 2021 | 380 daysLate | Root Jonathan DDirector | PPurchase | +2.36K | $15.25 | +$36.0K | New position2.36K after | 2 lots |